These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6407845)
1. Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine. Bartholeyns J Eur J Cancer Clin Oncol; 1983 Apr; 19(4):567-72. PubMed ID: 6407845 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Fozard JR; Part ML; Prakash NJ; Grove J Eur J Pharmacol; 1980 Aug; 65(4):379-91. PubMed ID: 6773783 [TBL] [Abstract][Full Text] [Related]
3. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Sunkara PS; Rosenberger AL Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031 [TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma. Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502 [TBL] [Abstract][Full Text] [Related]
5. Effects of DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene. Fozard JR; Prakash NJ Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):72-7. PubMed ID: 6811956 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers. Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786 [TBL] [Abstract][Full Text] [Related]
7. Indirect evidence for a strict negative control of S-adenosyl-L-methionine decarboxylase by spermidine in rat hepatoma cells. Mamont PS; Joder-Ohlenbusch AM; Nussli M; Grove J Biochem J; 1981 May; 196(2):411-22. PubMed ID: 6797404 [TBL] [Abstract][Full Text] [Related]
8. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study]. Dunzendorfer U; Knöner M Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811 [TBL] [Abstract][Full Text] [Related]
9. The role of polyamine depletion and accumulation of decarboxylated S-adenosylmethionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine. Pegg AE Biochem J; 1984 Nov; 224(1):29-38. PubMed ID: 6439194 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine. Takigawa M; Verma AK; Simsiman RC; Boutwell RK Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752 [TBL] [Abstract][Full Text] [Related]
11. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs. Claverie N; Mamont PS Cancer Res; 1989 Aug; 49(16):4466-71. PubMed ID: 2501026 [TBL] [Abstract][Full Text] [Related]
13. Reversal of the growth inhibitory effect of alpha-difluoromethylornithine by putrescine but not by other divalent cations. Oredsson SM; Anehus S; Heby O Mol Cell Biochem; 1984 Sep; 64(2):163-72. PubMed ID: 6438490 [TBL] [Abstract][Full Text] [Related]
14. In vivo effects of DL-alpha-difluoromethylornithine on the polyamine and nucleotide phosphate metabolism in P388/S leukemia cells. Kremmer T; Boldizsár M; Holczinger L Exp Cell Biol; 1986; 54(1):8-15. PubMed ID: 3082689 [TBL] [Abstract][Full Text] [Related]
15. Polyamines regulate human medullary thyroid carcinoma TT-cell proliferation and secretion of calcitonin and calcitonin gene-related peptide. Sjöholm A; Bucht E; Theodorsson E; Larsson R; Nygren P Mol Cell Endocrinol; 1994 Jul; 103(1-2):89-94. PubMed ID: 7958401 [TBL] [Abstract][Full Text] [Related]
16. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128 [TBL] [Abstract][Full Text] [Related]
17. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine. Mamont PS; Danzin C; Kolb M; Gerhart F; Bey P; Sjoerdsma A Biochem Pharmacol; 1986 Jan; 35(2):159-65. PubMed ID: 3080004 [TBL] [Abstract][Full Text] [Related]
18. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition. Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice. Luk GD; Abeloff MD; Griffin CA; Baylin SB Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400 [TBL] [Abstract][Full Text] [Related]
20. Polyamines and the development of monocrotaline-induced pulmonary hypertension. Olson JW; Hacker AD; Altiere RJ; Gillespie MN Am J Physiol; 1984 Oct; 247(4 Pt 2):H682-5. PubMed ID: 6437245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]